a new extended release oral dosage form

Details for Australian Patent Application No. 2002327992 (hide)

Owner ASTRAZENECA AB

Inventors Ringberg, Anders; Schweighofer, Annika; Kjellberg, Ulf; Ellstrom, Karin; Nyqvist, Hakan

Agent Freehills

Pub. Number AU-A-2002327992

PCT Number PCT/SE02/01541

PCT Pub. Number WO2003/017983

Priority 0102887-7 29.08.01 SE

Filing date 28 August 2002

Wipo publication date 10 March 2003

International Classifications

A61K 009/22 Medicinal preparations characterised by special physical form - Sustained or differential release type

A61P 025/00 Drugs for disorders of the nervous system

A61P 025/04 Drugs for disorders of the nervous system

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 0102887-7 29.08.01 SE

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002327992

23 March 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002327993-A NEW EXTENDED RELEASE ORAL DOSAGE FORM

2002327991-A new extended release oral dosage form